Light Mode
$145.27 ↑ +0.00 (+0.00%) Trading Up from the previous close of $145.27, $0.17 below the day’s high of $145.44
+33.37 (+29.82%) / 6M
Momentum, market sentiment, and recent alerts
MRK reads neutral: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is +66.0%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.